Endo

$2.80
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.02 (-0.53%) As of 1:19 PM EDT today
-$0.02 (-0.53%) Today

Why Robinhood?

You can buy or sell Endo and other stocks, options, ETFs, and crypto commission-free!

About ENDP

Endo International Plc operates as a pharmaceutical company. It focuses on developing, manufacturing, and distributing of branded and generic pharmaceutical products. Read More The firm operates through the following segments: U.S. Branded-Specialty & Established Pharmaceuticals, U.S. Branded-Sterile Injectables, U.S. Generic Pharmaceuticals and International Pharmaceuticals. The U.S. Branded-Specialty & Established Pharmaceuticals segment offers prescription products to treat and manage conditions in urology, urologic oncology, endocrinology, pain and orthopedics. The U.S. Branded-Sterile Injectables segment consists primarily of branded sterile injectable products such as VASOSTRICT, ADRENALIN and APLISOL, among others, and certain generic sterile injectable products, including ertapenem for injection and ephedrine sulfate injection, among others. The U.S. Generic Pharmaceuticals segment consists of a differentiated product portfolio including solid oral extended-release, solid oral immediate-release, liquids, semi-solids, patches, powders, ophthalmics and sprays and includes products in the pain management, urology, central nervous system disorders, immunosuppression, oncology, women's health and cardiovascular disease markets, among others. The International Pharmaceuticals segment includes a variety of pharmaceutical products for the Canadian, Latin American, South African, and world markets. The company was founded in 1997 and is headquartered Dublin, Ireland.

Employees
2,910
Headquarters
Dublin, Dublin
Founded
1997
Market Cap
636.16M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
7.26M
High Today
$2.89
Low Today
$2.71
Open Price
$2.77
Volume
4.01M
52 Week High
$18.50
52 Week Low
$2.14

Collections

ENDP News

ReutersAug 20

Drugmakers Endo, Allergan agree to $15 million in settlements in major opioid case

913
MarketWatchAug 20

Endo's stock soars after settlement agreement on track 1 opioid cases

1,012
ReutersAug 20

Drugmaker Endo to pay $10 million to settle opioid lawsuit

94

ENDP Earnings

$0.43
$0.54
$0.66
$0.77
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
Actual
Expected Nov 7, After Hours

More ENDP News

ReutersAug 20

PRESS DIGEST- Wall Street Journal - Aug 20

209
Wall Street JournalAug 19

Two Drugmakers Closing In on Opioid Settlements

216
ReutersAug 6

Endo settles investor case over withdrawn opioid for $82.5 million

404
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.